This finding was confirmed by gene set enrichment analyses, which showed that the IkB‐ζ target gene signature was enriched in a gene set that distinguishes ABC from other lymphoma subtypes, suggesting that these target genes are indeed expressed at higher levels in primary ABC DLBCL patient samples compared with other malignant lymphoma subtypes. This evidence concerns the gene NFKBIZ and lymphoma.